Thyroidectomy without Radioiodine in Patients with Low-Risk Thyroid Cancer
In this randomized phase 3 trial involving patients with low-risk differentiated thyroid cancer undergoing thyroidectomy, a follow-up strategy that did not involve the use of radioiodine was noninferior to the use of radioiodine in the response to treatment at 3 years.
Saved in:
Published in | The New England journal of medicine Vol. 386; no. 10; pp. 923 - 932 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Massachusetts Medical Society
10.03.2022
|
Subjects | |
Online Access | Get full text |
ISSN | 0028-4793 1533-4406 1533-4406 |
DOI | 10.1056/NEJMoa2111953 |
Cover
Summary: | In this randomized phase 3 trial involving patients with low-risk differentiated thyroid cancer undergoing thyroidectomy, a follow-up strategy that did not involve the use of radioiodine was noninferior to the use of radioiodine in the response to treatment at 3 years. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3 |
ISSN: | 0028-4793 1533-4406 1533-4406 |
DOI: | 10.1056/NEJMoa2111953 |